Advances On Endostatin In The Treatment Of Cervical Cancer Combined With Radiotherapy

Cervical cancer is one of the most common gynecologic malignancies. In the early state of cervical cancer radical surgery and radiotherapy have satisfactory results, however, for the advanced (â…¡b-â…£a) and recurrent cervical cancer radiotherapy plays a main role. But there are still ineffective case because of radiotherapy resistance. The recombinant human endostatin (Endostar) is a novel drugs that can inhibits the proliferation and migration of vascular endothelium, thereby inhibiting tumor angiogenesis, and increasing the radiosensitivity in cancer radiation treatment. This article is a research summary about the therapy of endostatin combined with radiotherapy in cervical cancer.